# Effect of Sevoflurane and Desflurane on Heme Oxygenase-1 Expression in Elective Cholecystectomy

> **NCT06457958** · PHASE4 · WITHDRAWN · sponsor: **Kocaeli City Hospital**

## Conditions studied

- Cholecystitis, Chronic

## Interventions

- **DRUG:** Sevoflurane Group
- **DRUG:** Desflurane Group

## Key facts

- **NCT ID:** NCT06457958
- **Lead sponsor:** Kocaeli City Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-06-01
- **Primary completion:** 2025-08-01
- **Final completion:** 2025-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Terminated due to lack of financial support.
- **Last updated:** 2025-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06457958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06457958, "Effect of Sevoflurane and Desflurane on Heme Oxygenase-1 Expression in Elective Cholecystectomy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06457958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*